patisiran

Italy

Drugs containing this active substance

  • ONPATTRO

    Onpattro is used for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis), a disease passed from one generation to another caused by problems with the transthyretin (TTR) protein.

    Form: solution for infusion, concentrate

    Active substance Dosage
    patisiran -

    ATC: N07XX12

    Manufacturer: ALNYLAM NETHERLANDS BV